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Abstract
Background: Concerns regarding reduced fetal movements (RFM) are reported in 5–15% of pregnancies, and RFM
are associated with adverse pregnancy outcomes including fetal growth restriction and stillbirth. Studies have
aimed to improve pregnancy outcomes by evaluating interventions to raise awareness of RFM in pregnancy, such
as kick counting, evaluating interventions for the clinical management of RFM, or both. However, there is not
currently a core outcome set (COS) for studies of RFM. This study aims to create a COS for use in research studies
that aim to raise awareness of RFM and/or evaluate interventions for the clinical management of RFM.
Methods: A systematic review will be conducted, to identify outcomes used in randomised and non-randomised
studies with control groups that aimed to raise awareness of RFM (for example by using mindfulness techniques,
fetal movement counting, or other tools such as leaflets or mobile phone applications) and/or that evaluated the
clinical management of RFM.
An international Delphi consensus will then be used whereby stakeholders will rate the importance of the
outcomes identified in the systematic review in (i) awareness and (ii) clinical management studies. The preliminary
lists of outcomes will be discussed at a consensus meeting where one final COS for awareness and management,
or two discrete COS (one for awareness and one for management), will be agreed upon.
Discussion: A well-developed COS will provide researchers with the minimum set of outcomes that should be
measured and reported in studies that aim to quantify the effects of interventions.
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Background
Reduced fetal movement and adverse pregnancy
outcome
Reduced fetal movements (RFM) are usually defined as a
subjective decrease or change in a baby’s typical pattern
of movements in utero [1]; current guidance in the UK
and Australia is for anyone pregnant to contact a mid-
wife or maternity unit if their baby is moving less than
usual or not at all [2, 3]. Most pregnant people become
aware of fetal movements by 18–20 weeks’ gestation, the
pattern of their baby’s movements, and the time of day
that the baby moves the most by 28 weeks’ gestation [4].
Awareness of fetal activity is recognised as one compo-
nent of maternal-fetal attachment [5].
Maternal concern regarding RFM leads to a presenta-
tion at the hospital in 5–15% of pregnancies [6]. Around
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70% of these pregnancies have a normal outcome [7–9],
but observational studies have recurrently demonstrated
that RFM are associated with adverse pregnancy out-
comes, including fetal growth restriction (FGR) and still-
birth, supporting the potential for a common aetiology
[10, 11]. Case-control studies have consistently demon-
strated an association between reduced frequency and
strength of fetal movements and stillbirth after 28 weeks’
gestation [12–14]; this effect has also been seen in low-
income settings [15]. It is thought that RFM may be an
attempt by the fetus to conserve energy and oxygen con-
sumption in cases of insufficient nutrient transfer and
hypoxia, which in turn may be caused by placental insuf-
ficiency or other fetal stressors [16–18].
Studies of awareness of or interventions for reduced fetal
movement
Studies have aimed to improve pregnancy outcomes by
evaluating interventions that raise maternal and/or clin-
ical awareness of RFM, such as mindfulness or kick
counting [19, 20], and/or by evaluating clinical manage-
ment interventions, for example, interventions com-
prised of further monitoring and/or clinical testing such
as cardiotocography (CTG) or ultrasound (US) to iden-
tify whether RFM is an indicator of an underlying condi-
tion that may warrant further clinical intervention or
even expedited birth [21, 22].
Despite the association between RFM, stillbirth and
FGR, a core outcome set (COS) for studies evaluating in-
terventions that aim to raise awareness of RFM and/or
studies evaluating the clinical management of RFM does
not currently exist. This means that studies often meas-
ure and report different outcomes and employ different
definitions for these outcomes, hindering meta-analysis
of studies. A COS describes a standardised set of out-
comes that should be measured and reported in all stud-
ies in a specific area as a minimum [23]; COS are
currently in use across several healthcare fields, includ-
ing maternity care [24–26]. It is anticipated that devel-
oping a COS will ensure that the most important and
relevant outcomes, as agreed by stakeholder consensus,
are measured, thus optimising the synthesis of individual
studies. This will further facilitate data synthesis and in-




This protocol describes the development of a COS for
measurement and reporting in studies that aim to raise
awareness of RFM and/or evaluate the clinical manage-
ment of RFM. Development and adoption of this COS
will ensure consistent and relevant outcome measure-
ment and reporting in studies for raising awareness and/
or evaluating the clinical management of RFM, which
may lead to more robust results, improved wellbeing in
pregnancy, and may also be applicable in clinical
practice.
This COS will apply to controlled randomised and
non-randomised study designs, as described in Table 1.
Objectives
1. To systematically review the outcomes included in
intervention studies for raising awareness of RFM
and/or evaluating its clinical management
2. To develop a consensus on a preliminary COS
using these outcomes via the Delphi survey
3. To develop a final COS for use in all future
intervention studies aimed at raising awareness of
RFM and/or evaluating the clinical management of
RFM, via an international consensus meeting with
key stakeholders
4. To disseminate and promote the use of the COS
Design
The COS development project was registered with the
Core Outcome Measures in Effectiveness Trials
(COMET) initiative (http://comet-initiative.org/Studies/
Details/928) on the 24th of September 2020.
This protocol was developed in accordance with the
COMET handbook [23]. A study steering committee will
be established comprised of at least one representative
from the following relevant stakeholder groups: re-
searchers, clinicians, and patients (described in more de-
tail later). We will include at least one representative
from low- or middle-income countries on the steering
committee.
Stage 1: Systematic review
A systematic review of the literature will be conducted
to identify outcomes measured in studies of interven-
tions where the intervention is designed to raise aware-
ness of RFM and/or evaluate the clinical management of
RFM.
The target population is women with non-anomalous
singleton pregnancies after 28 weeks’ gestation; this
threshold has been chosen over other definitions of still-
birth in order to facilitate international comparisons
[27]. We will not include studies of multiple pregnancies
because observational data about the association be-
tween RFM and adverse outcome in this group is less
clear.
We will include controlled randomised and non-
randomised studies with clearly reported mechanisms of
group formation, clearly defined inclusion criteria, and
clearly described methods of ascertainment of eligible
patients and their recruitment. Studies will be included
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regardless of their publication status and language of
publication.
Pregnancy, labour, and birth outcomes will be ex-
tracted with their corresponding definitions where pos-
sible. Outcomes will be grouped as maternal or
neonatal, and different definitions of the same outcome
will be grouped into single outcome measures. This will
be facilitated by discussions between members of the
study team. This final list of outcomes will be used in
stage two.
We will search the following databases: MEDLINE,
MEDLINE (In-Process and Other Non-Indexed Cita-
tions), Embase, EBSCO CINAHL Plus, the Cochrane
Central Register of Controlled Trials (CENTRAL), the
Cochrane Pregnancy and Childbirth’s Trials Register,
and the Cochrane Database of Systematic Reviews.
Other trial registries such as clinicaltrials.gov, WHO
ICTRP, and the EU clinical trials register will also be
searched, as well as databases such as OpenGrey (www.
opengrey.eu), Joanna Briggs Institute (www.joannabriggs.
edu.au), and the National Institute for Health and Clin-
ical Excellence website (NICE; www.nice.org.uk) to find
unpublished studies. Reference lists of included papers
will be reviewed for additional studies. The search strat-
egy for this COS is provided as an additional file.
Studies identified by the literature searches will be in-
dependently screened for inclusion by two study authors
using our study inclusion criteria (Table 1). Disagree-
ments will be resolved by consulting a third author. The
following data will be extracted from included studies:
study aim, location, population, setting, description of
the intervention and comparator, and outcomes reported
in the study.
Stage 2: Online international Delphi survey
A sequential three-round electronic international Delphi
study will be conducted using REDCap v10.1.2 including
key stakeholders to produce a preliminary COS. Each
round will remain open for at least 14 days, and a re-
minder email will be sent out three working days before
closure. Data from each round will be analysed and pre-
sented to participants in the next round (described in
more detail below). Attrition rates for each round will
also be assessed. All participants’ contact information
will remain confidential.
The Delphi survey and following consensus meeting
will allow the possibility of producing either one COS
(for all studies relating to raising awareness and/or
evaluating the clinical management of RFM) or two
COS (one for studies raising awareness of RFM and an-
other for studies evaluating the clinical management of
RFM). This will be dependent on whether there is sig-
nificant overlap or similarity in the final outcomes in the
two lists. This follows the precedent set by other COS in
maternity care that have started by running two surveys
simultaneously and then voted on whether one COS
should be produced [26, 28].
Participants
We will invite people from all stakeholder groups, aim-
ing for at least 15 people from each of the following
three groups to ensure adequate representation. Eligible
participants will be (1) researchers, research funders, and
policymakers who are actively involved in work related
to RFM; (2) clinicians (midwives, obstetricians, neonatol-
ogists, GPs/family physicians) with experience of caring
for women with RFM; and (3) anyone who is or who has
been pregnant and their partners if applicable. We will
recruit participants through professional organisations,
electronic discussion lists, and patient organisations or
charities. As with the formation of the steering group,
we will ensure that participants from low-income coun-
tries are represented. Authors of all included studies will
be invited to participate; we will also use snowball sam-
pling, whereby we will request participants to forward
the survey to others who they consider eligible to
participate.
Participants of the Delphi survey will receive all infor-
mation regarding the study as part of the invitation
email. Consent to take part in the survey will be ensured
by requiring participants to click an ‘I agree to take part’
box before gaining access to the survey. All personal
data of participants will only be accessible to members
of the research team and any response to the survey will
be confidential. Participants will have the right to with-
draw at any point.
Round 1
Round 1 will collect demographic data including nation-
ality, age, stakeholder group, and role. Participants will
Table 1 Study inclusion criteria for the systematic review
Population Singleton pregnancies presenting at least once in a maternity care setting after 28 weeks’ gestation
Intervention Any intervention aimed at raising awareness of RFM and/or evaluating the clinical management of RFM
Comparator Any other intervention described above or no intervention
Outcome Any maternal or fetal outcomes
Study
design
Controlled randomised and non-randomised studies with clearly reported mechanism of group formation, clearly defined inclusion cri-
teria, and described methods of ascertainment of eligible patients and their recruitment
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be presented with a list of all outcomes identified from
the systematic review and will be asked to rate the im-
portance of each using a 9-point Likert scale. On this
scale, a score of 1–3 indicates limited importance, 4–6
signifies importance, and 7–9 is used for critically im-
portant outcomes. Participants will also be prompted to
add additional outcomes that they feel are important but
are not included in the preliminary list. Suggested out-
comes will be included in round 2 if they are mentioned
by at least two participants. All outcomes from round 1
will be forwarded to round 2.
Feedback will be provided to all who participated in
round 1 in the form of descriptive statistics and graph-
ical representations for ease of interpretation. For each
outcome, participants will receive their scores from the
first round and a graphical representation of the per-
centages of each group who voted for each score for
each outcome. All feedback provided to participants will
be anonymised.
Standardised consensus criteria will be applied to the
results from this round, which will be used through all
three rounds to reach the preliminary list of outcomes
to be included (Table 2). Outcomes that are not scored
by participants will not be included in analyses or con-
sensus definitions.
Round 2
Participants will be presented with their scores from the
previous round as well as feedback given in the same
way as described in round 1. All participants who com-
pleted the first round will be asked to re-score all out-
comes using the same 9-point Likert scale, including any
additional suggested outcomes from round 1, in light of
their and others’ ratings.
In round 2, outcomes will be presented in two lists.
Participants will be asked to rate the outcomes in each
list according to how important they think each out-
come is for measuring and reporting in studies of (i) in-
terventions for raising awareness of RFM and in studies
of (ii) interventions for the clinical management of RFM.
The ratings for the two separate lists will be reviewed
and analysed separately.
Outcomes will be included in round 3 if they are rated
as ‘consensus in’ or ‘no consensus’ using the consensus
criteria in Table 2; those rated as ‘consensus out’ will be
removed. Outcomes will be removed from lists (i) and
(ii) of the survey individually based on their ratings in
each list. We will also assess the rates of attrition from
each round and whether participants change their scores
based on the feedback they receive.
Round 3
Round 3 will only include participants who completed
round 2. Participants will again be provided with feed-
back and asked to re-rate the outcomes retained from
round 2 in the same way as in round 2, in two separate
lists for (i) RFM awareness studies and (ii) RFM clinical
management studies using the 9-point Likert scale. The
consensus criteria will again be used to determine which
outcomes are retained in each distinct outcome list fol-
lowing this round and forwarded to the consensus meet-
ing. Those defined as ‘consensus out’ and ‘no consensus’
will be removed. Round 3 will include a question asking
if participants are willing to take part in the final con-
sensus meeting and if they consent to being contacted.
Stage 3: Consensus meeting
A consensus meeting with an international panel repre-
senting views of all key stakeholders will be held to dis-
cuss, vote, and agree on the final RFM COS. This
meeting will include a presentation of the findings of the
round 3 Delphi, including the final list of outcomes by
category (i.e. awareness and clinical management) and
how they were voted for by each stakeholder group. This
will be followed by a timed discussion and a vote on
each outcome for each list. Outcomes will be included if
voted for by at least 70% of participants, including at
least one from each stakeholder group.
The final COS for (i) interventions for raising aware-
ness of RFM and (ii) interventions for the clinical man-
agement of RFM will then be compared. If the outcomes
included in these two COS lists are largely the same,
then a majority vote will be held on whether to combine
the lists to produce one COS for studies of both the
awareness and clinical management of RFM. If the out-
comes in the lists are different, then two separate COS
will be created.
The consensus panel will be comprised of at least
three representatives from each stakeholder group de-
scribed earlier. The meeting will be held in English and
group facilitators will be used for discussions. Due to the
COVID-19 pandemic and in order to facilitate inter-
national attendance, we are planning that this meeting
will be online.
Stage 4: Dissemination
The final COS will be published in an open-access jour-
nal. After publication, it will be made available through




Scored as 7–9 by 70% or more of all participants,
including at least one from each stakeholder group, and
as 1–3 by less than 15% of participants
Consensus
out




Any other combination of scores
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the COMET and CoRe Outcomes in Women’s and
Newborn health (CROWN) databases. In addition, we
plan to disseminate the COS at national and inter-
national conferences and through relevant professional
and patient organisations. We will share the COS with
clinical trial registries and relevant consumer groups
such as maternity service users and will ask all partici-
pants to share as they see appropriate.
Discussion
Research into the management of RFM was identified by
the Stillbirth Priority Setting Partnership (PSP) which
prioritised the question ‘Which investigations identify a
fetus which is at risk of stillbirth after a mother believes
she has experienced reduced fetal movements?’ [29].
The PSP had extensive input from researchers, clini-
cians, stakeholder groups, and bereaved parents. How-
ever, there is currently no published COS for studies
that evaluate interventions to raise awareness of RFM
and/or for the clinical management of RFM. A well-
developed COS for research studies that aim to quantify
the effects of these interventions will provide researchers
with a minimum set of outcomes that should be re-
corded, facilitating comparisons of interventions. We
have taken steps to ensure that pregnant women and
their views are adequately represented in this study and
the final COS.
Trial status
Protocol version 1.1, 4th November 2021. Recruitment
for the first round of the Delphi survey has begun.
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